BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to NCI-N87 cell line is 233
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | Trastuzumab | SFA and FACs followed by RT-PCR and Western Blotting | NA | 0.6 | 1 | 25669984 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by RT-PCR and SFA | NA | 0.6 | 1 | 30543303 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.6 | 1 | 28461325 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.6 | 1 | 32606358 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by FACs | NA | 0.6 | 1 | 28404967 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by SFA | NA | 0.6 | 1 | 19415765 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by SFA | NA | 0.6 | 1 | 31073886 |
| CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | MACs followed by SFA | NA | 0.6 | 1 | 31048191 |
| LINGO2 | 21207 | HTM/LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA and Transcriptomics followed by RT-PCR and Western Blotting | NA | 0.52 | 0.0011 | 30696080 |
| USP22 | 12621 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA and Western Blotting | NA | 0.48 | 0.0032 | 30543303 |
| CD24 | 1645 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.28 | 0.456 | 30696080 |
| CD24 | 1645 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.456 | 28461325 |
| CD24 | 1645 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by FACs | NA | 0.28 | 0.456 | 28404967 |
| CD24 | 1645 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by SFA | NA | 0.28 | 0.456 | 19415765 |
| LGR5 | 4504 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0753 | 28446252 |
| MSI1 | 7330 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 28461325 |
| MYC | 7553 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 28446252 |
| MYC | 7553 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 28461325 |
| MYC | 7553 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 32606358 |
| MYC | 7553 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA | NA | 0.28 | 0.1304 | 30543303 |
| NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 28461325 |
| NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 32606358 |
| NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA | NA | 0.28 | 0.5461 | 30543303 |
| NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.5461 | 30696080 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 28461325 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 32606358 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | Trastuzumab | SFA and Western Blotting | NA | 0.28 | 0.6448 | 25669984 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA | NA | 0.28 | 0.6448 | 30543303 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.6448 | 30696080 |
| PROM1 | 9454 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.7582 | 28461325 |
| PROM1 | 9454 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by FACs | NA | 0.28 | 0.7582 | 28404967 |
| PROM1 | 9454 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by SFA | NA | 0.28 | 0.7582 | 31073886 |
| PROM1 | 9454 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | MACs followed by SFA | NA | 0.28 | 0.7582 | 31048191 |
| RAC1 | 9801 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0032 | 28461325 |
| SOX2 | 11195 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 28446252 |
| SOX2 | 11195 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 28461325 |
| SOX2 | 11195 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 32606358 |
| FZD7 | 4045 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.2 | 0.0064 | 30696080 |
| BMI1 | 1066 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.1135 | 30543303 |
| CSPG4 | 2466 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.0011 | 30543303 |
| CTNNB1 | 2514 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0647 | 30696080 |
| FZD7 | 4045 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0064 | 30696080 |
| GLI1 | 4317 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | 5-Fluorouracil | SFA followed by qRT-PCR | NA | 0.2 | 0.0308 | 28847472 |
| GLI1 | 4317 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0308 | 30696080 |
| GLI2 | 4318 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | 5-Fluorouracil | SFA followed by qRT-PCR | NA | 0.2 | 0.0106 | 28847472 |
| HES1 | 5192 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0095 | 30696080 |
| JAG2 | 6189 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0032 | 30696080 |
| NOTCH3 | 7883 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0085 | 30696080 |
| PTEN | 9588 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0053 | 30696080 |
| SMO | 11119 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.0212 | 30543303 |
| SMO | 11119 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0212 | 30696080 |
| EPCAM | 11529 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by SFA | NA | 0.12 | 0.211 | 31073886 |
| FIT3 | NA | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs | NA | 0.12 | 0.0011 | 19415765 |
| FUT4 | 4015 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs | NA | 0.12 | 0.0085 | 19415765 |
| THY1 | 11801 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by FACs | NA | 0.12 | 0.0371 | 28404967 |
| THY1 | 11801 | LTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | FACs followed by SFA | NA | 0.12 | 0.0371 | 31073886 |
| ABCF2 | 71 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| ABCF2 | 71 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| ABCF2 | 71 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| ABCF2 | 71 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| ADAM22 | 201 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| ADGRB3 | 945 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| AHNAK2 | 20125 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| AKAP12 | 370 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| AMH | 464 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| ANO3 | 14004 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| ARHGAP29 | 30207 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| ARL4C | 698 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| ARMCX3 | 24065 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| ARSD | 717 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| ASNS | 753 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| BCL11A | 13221 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| BIRC3 | 591 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| C15ORF48 | 29898 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| CALB1 | 1434 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| CALD1 | 1441 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| CAV1 | 1527 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 30696080 |
| CAV2 | 1528 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 30696080 |
| CBX5 | 1555 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| CCL5 | 10632 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080 |
| CCND1 | 1582 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0201 | 30696080 |
| CD36 | 1663 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| CD55 | 2665 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| CDH19 | 1758 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| CDKN2AIPNL | 30545 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| CEP350 | 24238 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| CFAP44 | 25631 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| CFAP70 | 30726 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| CHGB | 1930 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| CLDN1 | 2032 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| CLIC3 | 2064 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| CLU | 2095 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080 |
| CNTNAP3 | 13834 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| COL1A1 | 2197 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| COL21A1 | 17025 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| COTL1 | 18304 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| CPE | 2303 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080 |
| CRYZL1 | 2420 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| CSMD3 | 19291 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| CXCL1 | 4602 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080 |
| CYR61 | 2654 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| DDIT4 | 24944 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| DHX9 | 2750 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 30696080 |
| DKK3 | 2893 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| DNER | 24456 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| DOCK10 | 23479 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| DPY19L2 | 19414 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| DSC1 | 3035 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| DST | 1090 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| DTNA | 3057 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| EDN3 | 3178 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| EFEMP1 | 3218 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080 |
| EGFR | 3236 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 30696080 |
| EMP1 | 3333 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| EMP3 | 3335 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| EPHA5 | 3389 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| ETS1 | 3488 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| F2R | 3537 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| F2RL1 | 3538 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| FAT4 | 23109 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| FGF2 | 3676 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| FH | 3700 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| FHL2 | 3703 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| FOLR1 | 3791 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 30696080 |
| FOXF1 | 3809 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| FSTL3 | 3973 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| GADD45B | 4096 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| GEM | 4234 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| GIGYF2 | 11960 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| GPATCH2 | 25499 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| GRAMD2B | 24911 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080 |
| GRK6 | 4545 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| HGF | 4893 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| HOMER1 | 17512 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| ID2 | 5361 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 30696080 |
| ID2B | 30656 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| ID4 | 5363 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080 |
| IGF1 | 5464 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 30696080 |
| IGFBP6 | 5475 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| IL8 | 6025 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 30696080 |
| ITGA2 | 6137 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 30696080 |
| JAM2 | 14686 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| KAZN | 29173 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| KCNN4 | 6293 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| KDR | 6307 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| KLF5 | 6349 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| KLHL1 | 6352 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| KMT5B | 24283 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| LAMP3 | 14582 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| LIPA | 6617 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| LMO3 | 6643 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| LONP2 | 20598 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| LOX | 6664 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 30696080 |
| LRATD2 | 24166 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| LRFN5 | 20360 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| LRRN3 | 17200 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| LY6E | 6727 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| MALAT1 | 29665 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 30696080 |
| MDFIC | 28870 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| MICAL2 | 24693 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| MICB | 7091 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| MMP1 | 7155 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| MSL1 | 27905 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| MUC15 | 14956 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| MYO10 | 7593 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| MZF1 | 13108 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| NABP1 | 26232 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| NAV2 | 15997 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| NAV3 | 15998 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| NCEH1 | 29260 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| NEBL | 16932 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| NEXMIF | 29433 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| NLGN1 | 14291 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| NNMT | 7861 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| NOX4 | 7891 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| NREP | 16834 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| NT5E | 8021 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0095 | 30696080 |
| NUCB2 | 8044 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| P2RY1 | 8539 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| PALLD | 17068 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| PAPPA | 8602 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| PCDH9 | 8661 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| PDLIM7 | 22958 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| PHLDA1 | 8933 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| PHLDA2 | 12385 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| PLAG1 | 9045 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| PLAU | 9052 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| PLGLA | 9074 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| PLXDC2 | 21013 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| POSTN | 16953 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080 |
| PROCR | 9452 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| PROSER2 | 23728 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| PRPS1 | 9462 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| PRSS23 | 14370 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| PSAT1 | 19129 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| PSMB9 | 9546 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| PTK2 | 9611 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| PTPRK | 9674 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| QKI | 21100 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| RAB31 | 9771 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| RBM24 | 21539 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SAMD9 | 1348 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SAT1 | 10540 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 30696080 |
| SCIN | 21695 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| SCUBE3 | 13655 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| SDC2 | 10659 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 30696080 |
| SELENOP | 10751 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| SERPINB2 | 8584 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| SGK1 | 10810 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| SGSH | 10818 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| SH3BP4 | 10826 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| SLC16A6 | 10927 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SLC6A15 | 13621 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SNCA | 11138 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SOCS3 | 19391 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SOX9 | 11204 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0244 | 30696080 |
| SPHK1 | 11240 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SPOCK1 | 11251 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| SPX | 28139 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| SRPX | 11309 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| SWAP70 | 17070 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| SYCP2 | 11490 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 30696080 |
| TFAP2C | 11744 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| THBS1 | 11785 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 30696080 |
| TM4SF1 | 11853 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 30696080 |
| TNS3 | 21616 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 30696080 |
| TOX2 | 16095 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| TRIM73 | 18162 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| TRIP10 | 12304 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 30696080 |
| ULBP2 | 14894 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 30696080 |
| XXYLT1 | 26639 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 30696080 |
| ZMAT1 | 29377 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |
| ZNF436 | 20814 | HTM | Gastric Cancer | Carcinoma | NCI-N87 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 30696080 |